Women’s health innovator Evofem Biosciences, Inc. (OTCQB: EVFM) announced in a press release today a new market partnership with telemedicine company Hello Alpha to offer an FDA-approved solution to prevent pregnancy for those who choose to use an on-demand method of birth control.
Hello Alpha is a telemedicine company with a medical team specifically trained for women’s unique needs. The solutions being offered by Hello Alpha and Evofem are designed to complement the use of GLP-1 medications, which can potentially reduce the effectiveness of birth control pills during specific intervals within the dosing cycle.
Shares were trading almost 20 percent higher in morning activity.
Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
View the original article on AllPennyStocks.com
]]>